The impact of genomics on vaccine design

Trends in Biotechnology

Volumn 23, Issue 2, 2005, Pages 84-91

  Scarselli, Maria ^a   Giuliani, Marzia M ^a   Adu Bobie, Jeannette ^a   Pizza, Mariagrazia ^a   Rappuoli, Rino ^a  

^a CHIRON VACCINES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ATTENUATION; BACTERIA; DISEASE CONTROL; DNA; GENES;

BIOINFORMATICS; DNA MICROARRAYS; PATHOGENS; VACCINOLOGY;

VACCINES;

BACTERIAL VACCINE; LIVE VACCINE; MENINGOCOCCUS VACCINE; VACCINE;

BACTERIAL GENETICS; BACTERIAL GENOME; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM; BIOINFORMATICS; BIOTECHNOLOGY; CAUSE OF DEATH; DNA MICROARRAY; DRUG DESIGN; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; DRUG TARGETING; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE SEQUENCE; GENE STRUCTURE; GENE TECHNOLOGY; GENETIC ANALYSIS; GENETIC SCREENING; GENETIC STABILITY; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOME ANALYSIS; GENOMICS; HISTORY OF MEDICINE; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOHISTOCHEMISTRY; INFECTION; INFECTION PREVENTION; INHIBITION KINETICS; MASS SPECTROMETRY; MEDICAL PRACTICE; MOLECULAR BIOLOGY; MOLECULAR EVOLUTION; MUTAGENESIS; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEOMICS; REVIEW; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SEROLOGY; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TWO DIMENSIONAL GEL ELECTROPHORESIS; VACCINATION;

BACTERIAL VACCINES; COMPUTATIONAL BIOLOGY; GENOME, BACTERIAL; GENOMICS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEOMICS;

BACTERIA (MICROORGANISMS);

EID: 12344276293     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibtech.2004.12.008     Document Type: Review

References (95)

1. G. Del Giudice, and R. Rappuoli Genetically derived toxoids for use as vaccines and adjuvants Vaccine 17 Suppl 2 1999 S44 S52
2. Andre, F.E. (1990) Overview of a 5-year clinical experience with a yeast-derived hepatitis B vaccine. Vaccine 8 Suppl, S74-78; discussion S79-80
3. M. Pizza Mutants of pertussis toxin suitable for vaccine development Science 246 1989 497 500
4. L. Nencioni Characterization of genetically inactivated pertussis toxin mutants: candidates for a new vaccine against whooping cough Infect. Immun. 58 1990 1308 1315
5. R. Rappuoli Reverse vaccinology, a genome-based approach to vaccine development Vaccine 19 2001 2688 2691
6. M. Pizza Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing Science 287 2000 1816 1820
7. H. Tettelin Complete genome sequence of Neisseria meningitidis serogroup B strain MC58 Science 287 2000 1809 1815
8. R. Grifantini Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarrays Nat. Biotechnol. 20 2002 914 921
9. N. Ariel Search for potential vaccine candidate open reading frames in the Bacillus anthracis virulence plasmid pXO1: in silico and in vitro screening Infect. Immun. 70 2002 6817 6827
10. T.M. Wizemann Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection Infect. Immun. 69 2001 1593 1598
11. H. Etz Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus Proc. Natl. Acad. Sci. U. S. A. 99 2002 6573 6578
12. O. Vytvytska Identification of vaccine candidate antigens of Staphylococcus aureus by serological proteome analysis Proteomics 2 2002 580 590
13. S. Montigiani Genomic approach for analysis of surface proteins in Chlamydia pneumoniae Infect. Immun. 70 2002 368 379
14. B.C. Ross Identification of vaccine candidate antigens from a genomic analysis of Porphyromonas gingivalis Vaccine 19 2001 4135 4142
15. P.S. Srinivasa Rao Functional Genomics Approach to the Identification of Virulence Genes Involved in Edwardsiella tarda Pathogenesis Infect. Immun. 71 2003 1343 1351
16. J.C. Betts Transcriptomics and proteomics: tools for the identification of novel drug targets and vaccine candidates for tuberculosis IUBMB Life 53 2002 239 242
17. D. Serruto Neisseria meningitidis App, a new adhesin with autocatalytic serine protease activity Mol. Microbiol. 48 2003 323 334
18. M. Comanducci NadA, a novel vaccine candidate of Neisseria meningitidis J. Exp. Med. 195 2002 1445 1454
19. M. Scarselli A common conserved amino acid motif module shared by bacterial and intercellular adhesins: bacterial adherence mimicking cell cell recognition? Microbiology 147 2001 250 252
20. I.R.A. Peak Identification and characterisation of a novel conserved outer membrane protein from Neisseria meningitidis FEMS Immunol. Med. Microbiol. 28 2000 329 334
21. V. Masignani Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870 J. Exp. Med. 197 2003 789 799
22. J. Adu-Bobie GNA33 of Neisseria meningitidis is a lipoprotein required for cell separation, membrane architecture and virulence Infect. Immun. 72 2004 1914 1919
23. V. Masignani NarE: a novel ADP-ribosyltransferase from Neisseria meningitidis Mol. Microbiol. 50 2003 1055 1067
24. H.A. Hadi Identification and characterization of App: an immunogenic autotransporter protein of Neisseria meningitidis Mol. Microbiol. 41 2001 611 623
25. E. Hoiczyk Structure and sequence analysis of Yersinia YadA and Moraxella UspAs reveal a novel class of adhesins EMBO J. 19 2000 5989 5999
26. L.D. Fletcher Vaccine potential of the Neisseria meningitidis 2086 lipoprotein Infect. Immun. 72 2004 2088 2100
27. G.T. Jennings GNA33 from Neisseria meningitidis serogroup B encodes a membrane-bound lytic transglycosylase (MltA) Eur. J. Biochem. 269 2002 3722 3731
28. J. Hacker, and J.B. Kaper Pathogenicity islands and the evolution of microbes Annu. Rev. Microbiol. 54 2000 641 679
29. U. Dobrindt Genomic islands in pathogenic and environmental microorganisms Nat. Rev. Microbiol. 2 2004 414 424
30. R.A. Welch Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli Proc. Natl. Acad. Sci. U. S. A. 99 2002 17020 17024
31. T. Hayashi Complete genome sequence of enterohemorrhagic Escherichia coli O157:H7 and genomic comparison with a laboratory strain K-12 DNA Res. 8 2001 11 22
32. J.A. Eisen Gastrogenomics Nature 409 2001 465 466
33. D.J. Banks The fundamental contribution of phages to GAS evolution, genome diversification and strain emergence Trends Microbiol. 10 2002 515 521
34. J.J. Ferretti Complete genome sequence of an M1 strain of Streptococcus pyogenes Proc. Natl. Acad. Sci. U. S. A. 98 2001 4658 4663
35. J.C. Smoot Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks Proc. Natl. Acad. Sci. U. S. A. 99 2002 4668 4673
36. S.B. Beres Genome-wide molecular dissection of serotype M3 group A Streptococcus strains causing two epidemics of invasive infections Proc. Natl. Acad. Sci. U. S. A. 101 2004 11833 11838
37. I. Nakagawa Genome sequence of an M3 strain of Streptococcus pyogenes reveals a large-scale genomic rearrangement in invasive strains and new insights into phage evolution Genome Res. 13 2003 1042 1055
38. P. Glaser Comparative genomics of Listeria species Science 294 2001 849 852
39. A.M. Cerdeno-Tarraga The complete genome sequence and analysis of Corynebacterium diphtheriae NCTC13129 Nucleic Acids Res. 31 2003 6516 6523
40. N. Ivanova Genome sequence of Bacillus cereus and comparative analysis with Bacillus anthracis Nature 423 2003 87 91
41. T.D. Read Genome sequence of Chlamydophila caviae (Chlamydia psittaci GPIC): examining the role of niche-specific genes in the evolution of the Chlamydiaceae Nucleic Acids Res. 31 2003 2134 2147
42. D.A. Rasko The genome sequence of Bacillus cereus ATCC 10987 reveals metabolic adaptations and a large plasmid related to Bacillus anthracis pXO1 Nucleic Acids Res. 32 2004 977 988
43. A.R. Hoffmaster Identification of anthrax toxin genes in a Bacillus cereus associated with an illness resembling inhalation anthrax Proc. Natl. Acad. Sci. U. S. A. 101 2004 8449 8454
44. H. Bruggemann The genome sequence of Clostridium tetani, the causative agent of tetanus disease Proc. Natl. Acad. Sci. U. S. A. 100 2003 1316 1321
45. K.E. Nelson Complete genome sequence and comparative analysis of the metabolically versatile Pseudomonas putida KT2440 Environ. Microbiol. 4 2002 799 808
46. J. Parkhill The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences Nature 403 2000 665 668
47. S. Garcia-Vallve Genetic variation between Helicobacter pylori strains: gene acquisition or loss? Trends Microbiol. 10 2002 445 447
48. S. Kalman Comparative genomes of Chlamydia pneumoniae and C. trachomatis Nat. Genet. 21 1999 385 389
49. T.D. Read Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39 Nucleic Acids Res. 28 2000 1397 1406
50. R. Brosch The evolution of mycobacterial pathogenicity: clues from comparative genomics Trends Microbiol. 9 2001 452 458
51. M.W. van der Woude, and A.J. Baumler Phase and antigenic variation in bacteria Clin. Microbiol. Rev. 17 2004 581 611
52. R.A. Alm Comparative genomics of Helicobacter pylori: analysis of the outer membrane protein families Infect. Immun. 68 2000 4155 4168
53. M.J. Brennan, and G. Delogu The PE multigene family: a 'molecular mantra' for mycobacteria Trends Microbiol. 10 2002 246 249
54. D. Cabanes Surface proteins and the pathogenic potential of Listeria monocytogenes Trends Microbiol. 10 2002 238 245
55. B. Wren The Yersiniae - a model genus to study the rapid evolution of bacterial pathogens Nat. Rev. Microbiol. 1 2003 55 64
56. A. Preston The Bordetellae: lessons from genomics Nat. Rev. Microbiol. 2 2004 379 390
57. T.S. Whittam, and A.C. Bumbaugh Inferences from whole-genome sequences of bacterial pathogens Curr. Opin. Genet. Dev. 12 2002 719 725
58. R.A. Alm Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori Nature 397 1999 176 180
59. R.D. Fleischmann whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains J. Bacteriol. 184 2002 5479 5490
60. M. Shirai Comparison of whole genome sequences of Chlamydia pneumoniae J138 from Japan and CWL029 from USA Nucleic Acids Res. 28 2000 2311 2314
61. P.A. Bryant Chips with everything: DNA microarrays in infectious diseases Lancet Infect. Dis. 4 2004 100 111
62. G.K. Schoolnik Functional and comparative genomics of pathogenic bacteria Curr. Opin. Microbiol. 5 2002 20 26
63. S. Kurz Transcriptome-based antigen identification for Neisseria meningitidis Vaccine 21 2003 768 775
64. A. Mueller Protective immunity against Helicobacter is characterized by a unique transcriptional signature Proc. Natl. Acad. Sci. U. S. A. 100 2003 12289 12294
65. M.J. Mahan Selection of bacterial virulence genes that are specifically induced in host tissues Science 259 1993 686 688
66. R.H. Valdivia, and S. Falkow Fluorescence-based isolation of bacterial genes expressed within host cells Science 277 1997 2007 2011
67. R.H. Valdivia, and S. Falkow Bacterial genetics by flow cytometry: rapid isolation of Salmonella typhimurium acid-inducible promoters by differential fluorescence induction Mol. Microbiol. 22 1996 367 378
68. R.H. Valdivia, and S. Falkow Probing bacterial gene expression within host cells Trends Microbiol. 5 1997 360 363
69. J.M. Slauch, and A. Camilli IVET and RIVET: use of gene fusions to identify bacterial virulence factors specifically induced in host tissues Methods Enzymol. 326 2000 73 96
70. M. Handfield IVIAT: a novel method to identify microbial genes expressed specifically during human infections Trends Microbiol. 8 2000 336 339
71. M. Hensel Simultaneous identification of bacterial virulence genes by negative selection Science 269 1995 400 403
72. L.R. Camacho Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis Mol. Microbiol. 34 1999 257 267
73. S.N. Coulter Staphylococcus aureus genetic loci impacting growth and survival in multiple infection environments Mol. Microbiol. 30 1998 393 404
74. J.M. Mei Identification of Staphylococcus aureus virulence genes in a murine model of bacteraemia using signature-tagged mutagenesis Mol. Microbiol. 26 1997 399 407
75. S.L. Chiang, and J.J. Mekalanos Use of signature-tagged transposon mutagenesis to identify Vibrio cholerae genes critical for colonization Mol. Microbiol. 27 1998 797 805
76. A.J. Darwin, and V.L. Miller Identification of Yersinia enterocolitica genes affecting survival in an animal host using signature-tagged transposon mutagenesis Mol. Microbiol. 32 1999 51 62
77. A. Polissi Large-scale identification of virulence genes from Streptococcus pneumoniae Infect. Immun. 66 1998 5620 5629
78. Y.H. Sun Functional genomics of Neisseria meningitidis pathogenesis Nat. Med. 6 2000 1269 1273
79. B.J. Akerley A genome-scale analysis for identification of genes required for growth or survival of Haemophilus influenzae Proc. Natl. Acad. Sci. U. S. A. 99 2002 966 971
80. C.A. Hutchison Global transposon mutagenesis and a minimal Mycoplasma genome Science 286 1999 2165 2169
81. C.M. Sassetti Genes required for mycobacterial growth defined by high density mutagenesis Mol. Microbiol. 48 2003 77 84
82. C.M. Sassetti Comprehensive identification of conditionally essential genes in mycobacteria Proc. Natl. Acad. Sci. U. S. A. 98 2001 12712 12717
83. G. Grandi Antibacterial vaccine design using genomics and proteomics Trends Biotechnol. 19 2001 181 188
84. C.L. Nilsson Identification of protein vaccine candidates from Helicobacter pylori using a preparative two-dimensional electrophoretic procedure and mass spectrometry Anal. Chem. 72 2000 2148 2153
85. O. Vytvytska Identification of vaccine candidate antigens of Staphylococcus aureus by serological proteome analysis Proteomics 2 2002 580 590
86. M.J. Hughes Identification of major outer surface proteins of Streptococcus agalactiae Infect. Immun. 70 2002 1254 1259
87. D.L. Doolan Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data Proc. Natl. Acad. Sci. U. S. A. 100 2003 9952 9957
88. N. Ariel Genome-based bioinformatic selection of chromosomal Bacillus anthracis putative vaccine candidates coupled with proteomic identification of surface-associated antigens Infect. Immun. 71 2003 4563 4579
89. H. Langen Two-dimensional map of the proteome of Haemophilus influenzae Electrophoresis 21 2000 411 429
90. K. Thoren Proteomic study of non-typable Haemophilus influenzae J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 782 2002 219 226
91. C.S. Klade Proteomics approaches towards antigen discovery and vaccine development Curr. Opin. Mol. Ther. 4 2002 216 223
92. J.C. Betts Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling Mol. Microbiol. 43 2002 717 731
93. J. Deiwick Proteomic approaches to Salmonella Pathogenicity Island 2 encoded proteins and the SsrAB regulon Proteomics 2 2002 792 799
94. D. Agudo A proteomic approach to study Salmonella typhi periplasmic proteins altered by a lack of the DsbA thiol: disulfide isomerase Proteomics 4 2004 355 363
95. P.R. Hardwidge Proteomic analysis of the intestinal epithelial cell response to enteropathogenic Escherichia coli J. Biol. Chem. 279 2004 20127 20136